Mental Health Status of People with Multiple Sclerosis during the COVID-19 Pandemic

Abstract

Objective. This study assesses and compares the mental health status of people with multiple sclerosis (PwMS) in Poland during the second wave of the Coronavirus Disease 2019 (COVID-19) pandemic (November 2020) to a similar group whose mental health status was examined in November 2017. It also analyzed the psychological resources such as self-efficacy and health locus of control (HLC) and their relationship to mental health in both groups. Methods. Cross-sectional study included two groups of PwMS with 113 respondents each. The respondents completed the General Health Questionnaire-12 and questionnaires for assessing self-efficacy and HLC. The clinical and demographic data of participants were also collected. Results. No differences in mental health status were observed between the studied groups. A hierarchical regression model of the group studied in 2020 revealed that general self-efficacy (β = −0.21, p = 0.032), HLC—internal (β = −0.21, p = 0.035), and education (β = −0.18, p = 0.048) explained 18% of the variance in the mental health of PwMS, whereas according to the model of the group assessed in 2017 self-efficacy (β = –0.31, p < 0.001), HLC—chance (β = 0.45, p < 0.001), and HLC—internal (β = −0.37, p < 0.001) explained 48% of the variance. Conclusions. Study results suggest that the pandemic and the related lockdown had no effect on the mental health status of PwMS. At the same time, it was noted that well known determinants of mental health such as self-efficacy and HLC seemed to retain their prominent role for mental functioning in the pandemic.

The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia

“…38 This discrepancy is perhaps because PwMS live with medical uncertainty from the time of diagnosis and thus have experience in dealing with the related discomfort. 32,39 The study results did not find that the type of medications used impacted PwMS' mental health. Past research regarding the behavioral practice of PwMS found that most did not stop taking their medications, though 46% reported experiencing fear and anxiety from taking disease-modifying therapy.…”

“… 38 This discrepancy is perhaps because PwMS live with medical uncertainty from the time of diagnosis and thus have experience in dealing with the related discomfort. 32 , 39 …”

Religious meaning system and life satisfaction: the mediating role of meaning in life among Polish people with multiple sclerosis

“…Taking into account the specificity of the study group, the course of MS is highly unpredictable and is usually characterized by relapses and periods of symptom remission. Uncertainty about treatment outcomes and the high rate of disability progression, as well as the side effects of the therapies used, make it difficult for patients to adjust psychologically to the disease state and have a significant impact on their daily functioning, mental health ( 76 , 77 ), quality of life ( 78 ) and ability to cope ( 79 ). The search for meaning in life dimension represents the motivational aspect of meaning in life, which requires commitment and increased activity ( 43 ).…”

Depressão e fadiga em mulheres com Esclerose Múltipla, após fim do isolamento social pela pandemia da Covid-19

“…Durante os anos de 2019 a 2022 a covid-19 se alastrou por todo o mundo, sendo considerada pela Organização Mundial de Saúde uma pandemia em março de 2020 (WILSKI M, et al, 2022). O isolamento social foi a medida mais segura instaurada em todos os países até o desenvolvimento das vacinas e efeito populacional esperado.…”